<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://biotechmorning.com/news/dna-predict-car-t-therapy-toxicity</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T14:21:56.296Z</news:publication_date>
      <news:title>Your DNA Might Predict Whether CAR-T Therapy Wrecks You</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/roche-walks-away-huntington-disease-twice</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T14:21:05.933Z</news:publication_date>
      <news:title>Roche Just Walked Away From Huntington&apos;s. Twice.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/fda-cder-staff-exodus-drug-review-crisis</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T14:20:12.465Z</news:publication_date>
      <news:title>The FDA&apos;s Drug Review Machine Is Running Out of People</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/eli-lilly-ataibeckley-psychedelic-depression-deal</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T14:19:18.261Z</news:publication_date>
      <news:title>Eli Lilly Just Bet $3.8 Billion That Psychedelics Can Fix Depression</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/fda-adcom-capricor-deramiocel-dmd-heart-drug</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T14:18:21.358Z</news:publication_date>
      <news:title>The Heart Drug the FDA Isn&apos;t Sure Actually Works</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/sanofi-kills-dupixent-successor-amlitelimab</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T14:17:30.800Z</news:publication_date>
      <news:title>Sanofi Just Killed Its Own Heir to the Throne</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/pfizer-penicillin-recall-syphilis-crisis</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T14:16:39.121Z</news:publication_date>
      <news:title>The Only Drug That Can Save These Babies Is Being Pulled Off Shelves</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/gsk-2-5-billion-restructuring-q2-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T14:15:47.276Z</news:publication_date>
      <news:title>GSK Just Lit $2.5 Billion on Fire. On Purpose.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/kailera-obesity-pill-side-effects-problem</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T14:25:58.612Z</news:publication_date>
      <news:title>Kailera&apos;s Obesity Pill Works. The Side Effects Might Kill the Deal.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/pancreatic-cancer-ras-inhibitor-daraxonrasib-fda</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T14:25:08.395Z</news:publication_date>
      <news:title>The Cancer That Stumped Drug Makers for 40 Years Just Met Its Match</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/fda-goes-dark-drug-rejections</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T14:24:15.628Z</news:publication_date>
      <news:title>The FDA Just Went Dark on Drug Rejections</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/vertex-10-billion-crinetics-acquisition</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T14:23:27.165Z</news:publication_date>
      <news:title>Vertex Just Bet $10 Billion on Your Hormones</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/zymeworks-acquires-theravance-929m-royalty-bet</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T14:22:33.571Z</news:publication_date>
      <news:title>The $929M Bet on a Drug That Already Failed Twice</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/awiqli-once-weekly-insulin-india-launch</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T14:21:33.359Z</news:publication_date>
      <news:title>One Shot a Week: The Insulin That Could Change Everything for 100 Million Indians</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/moderna-bird-flu-vaccine-phase-3-trial-2</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T14:20:31.950Z</news:publication_date>
      <news:title>Moderna&apos;s Betting on Bird Flu Before It Bets on Us</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/roche-walks-away-huntingtons-disease</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T14:19:38.587Z</news:publication_date>
      <news:title>Roche Just Walked Away From Huntington&apos;s Disease. Now What?</news:title>
    </news:news>
  </url>
</urlset>